The ovary-mediated FSH attenuation of the LH surge in the rat involves a decreased gonadotroph progesterone receptor (PR) action but not PR expression

J Endocrinol. 2008 Mar;196(3):583-92. doi: 10.1677/JOE-07-0223.

Abstract

Hyperstimulation of ovarian function with human FSH (hFSH) attenuates the preovulatory surge of LH. These experiments aimed at investigating the mechanism of ovarian-mediated FSH suppression of the progesterone (P(4)) receptor (PR)-dependent LH surge in the rat. Four-day cycling rats were injected with hFSH, oestradiol benzoate (EB) or vehicle during the dioestrous phase. On pro-oestrus, their pituitaries were studied for PR mRNA and protein expression. Additionally, pro-oestrous pituitaries were incubated in the presence of oestradiol-17beta (E(2)), and primed with P(4) and LH-releasing hormone (LHRH), with or without the antiprogestin RU486. After 1 h of incubation, pituitaries were either challenged or not challenged with LHRH. Measured basal and LHRH-stimulated LH secretions and LHRH self-priming were compared with those exhibited by incubated pituitaries on day 4 from ovariectomized (OVX) rats in metoestrus (day 2) injected with hFSH and/or EB on days 2 and 3. The results showed that: i) hFSH lowered the spontaneous LH surge without affecting basal LH and E(2) levels, gonadotroph PR-A/PR-B mRNA ratio or immunohistochemical protein expression; ii) incubated pro-oestrous pituitaries from hFSH-treated rats did not respond to P(4) or LHRH, and lacked E(2)-augmenting and LHRH self-priming effects and iii) OVX reversed the inhibitory effects of hFSH on LH secretion. It is concluded that under the influence of hFSH, the ovaries produce a non-steroidal factor which suppresses all PR-dependent events of the LH surge elicited by E(2). The action of such a factor seemed to be due to a blockade of gonadotroph PR action rather than to an inhibition of PR expression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Diestrus / drug effects
  • Diestrus / physiology
  • Estradiol / analogs & derivatives
  • Estradiol / pharmacology
  • Estrus / drug effects
  • Estrus / physiology
  • Female
  • Follicle Stimulating Hormone / metabolism
  • Follicle Stimulating Hormone, Human / pharmacology*
  • Follicular Phase / drug effects
  • Follicular Phase / physiology*
  • Gene Expression / drug effects
  • Gene Expression / physiology
  • Gonadotrophs / physiology*
  • Gonadotropin-Releasing Hormone / metabolism
  • Gonadotropin-Releasing Hormone / pharmacology
  • Humans
  • Luteinizing Hormone / metabolism*
  • Luteolytic Agents / pharmacology
  • Mifepristone / pharmacology
  • Ovariectomy
  • Ovary / physiology
  • Proestrus / drug effects
  • Proestrus / physiology
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Wistar
  • Receptors, Progesterone / genetics
  • Receptors, Progesterone / metabolism*
  • Uterus / drug effects
  • Uterus / physiology
  • Vagina / cytology
  • Vagina / drug effects
  • Vagina / physiology

Substances

  • Follicle Stimulating Hormone, Human
  • Luteolytic Agents
  • RNA, Messenger
  • Receptors, Progesterone
  • progesterone receptor A
  • progesterone receptor B
  • estradiol 3-benzoate
  • Mifepristone
  • Gonadotropin-Releasing Hormone
  • Estradiol
  • Luteinizing Hormone
  • Follicle Stimulating Hormone